Navigation Links
Arthritis Drug May Cause Liver Damage

According to a survey, a prescription drug for rheumatoid arthritis has been connected to dozens of serious liver injuries and 12 deaths which should be banned.// Arava began selling in 1998 as a competitor to the gold-standard treatment for rheumatoid arthritis, called methotrexate. When the Food and Drug Administration approved Arava, the agency noted Arava worked no better than the older drug, but said patients needed some different options.

According to Dr. Sidney Wolfe, FDA received many reports of severe liver toxicity linked to Arava use, including 50 hospitalizations and 10 deaths. Two of the deaths were people in their 20s. Since Arava and methotrexate work equally well, and methotrexate also bears a warning about possible liver damage, Wolfe compared the two. The FDA has six times more reports of liver damage among Arava users than methotrexate users - even though thousands more people use methotrexate.

Citing similar reactions abroad, the European Union last year warned patients and doctors about Arava's toxicity, Wolfe said. He wants the FDA to go further and ban Arava's sales. The FDA said it would carefully consider Wolfe's petition.

A spokeswoman for Arava manufacturer Aventis Pharma said she had not seen the petition and declined comment about liver damage. Lise Geduldig said Arava was ``an important therapeutic option'' taken by 200,000 people. The American College of Rheumatology last summer warned doctors to take special care in prescribing Arava, by repeatedly testing patients' livers for signs of harm.

Unlike other drugs that can clear the body shortly after patients swallow a dose, Arava can takes months to dissipate. According to him, there is not much doctors can do if a patient shows signs of trouble. Yet some insurance companies pay only for Arava, not more expensive newer therapies that do not come with the same risks.

Rheumatoid arthritis affects about 2 million Americans, the vast ma jority of them women. It is not the kind of arthritis that plagues the elderly as their joints essentially wear out. Instead, the immune system goes awry and attacks patients' own cartilage. It typically strikes between ages 25 and 50.

Liver damage is not the only Arava concern, Wolfe said. FDA records show more reports of lymphoma, high blood pressure and a life-threatening autoimmune disorder called Stevens-Johnson syndrome among Arava users compared with methotrexate, he said.


'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis drug can prolong life
7. New treatment for Rheumatoid Arthritis
8. Important cause of Arthritis
9. Personality Impacts Arthritis
10. New Rheumatoid Arthritis Treatment
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: